| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/23/2008 | EP1912665A2 Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus |
| 04/23/2008 | EP1420643B1 Enhancement of transfection of dna into the liver |
| 04/23/2008 | EP1344829B1 Paramyxovirus vector encoding fibroblast growth factor 2 (fgf2) and use thereof |
| 04/23/2008 | EP1284993B1 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella paraperussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions |
| 04/23/2008 | EP1238071B1 Uncharged antisense oligonucleotides targeted to bacterial 16s and 23s rrnas and their uses |
| 04/23/2008 | EP1220921B1 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 04/23/2008 | EP1142591B1 Gene carriers |
| 04/23/2008 | EP0763116B2 Recombinant viruses, preparation and use thereof in gene therapy |
| 04/23/2008 | CN101166762A Albumin-fused Kunitz domain peptides |
| 04/23/2008 | CN101166751A Inhibitor of peroxisome proliferator-activated receptor alpha coactivator 1 |
| 04/23/2008 | CN101166546A Topical administration permitting prolonged exposure of target cells to therapeutic and prophylactic nucleic acids |
| 04/23/2008 | CN101164624A Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 04/23/2008 | CN101164623A Compositions comprising viruses and methods for concentrating virus preparations |
| 04/23/2008 | CN101164621A Super-paramagnetic composite particle drug-loaded body and preparation method thereof |
| 04/22/2008 | US7361748 Protease for identifying modulators for treatment and prevention of thrombocytopenia and liver disorders |
| 04/22/2008 | US7361642 Development of hematological changes can be offset by recombinant growth hormone therapy; increases red blood cell and hemoglobin values |
| 04/22/2008 | US7361641 Methods and compositions for genomic modification |
| 04/22/2008 | US7361639 Gene therapy agent for Haemophilia B and its preparation method |
| 04/22/2008 | US7361511 Comparing gene expression levels in normal and tumor cells, diagnosis, treating with an antisense oligonucleotide, and monitoring results |
| 04/22/2008 | US7361505 Multipotent neural stem cell compositions |
| 04/22/2008 | US7361502 Nucleic acid molecule encoding a neuronal serine-threonine protein kinase |
| 04/22/2008 | US7361484 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents; exposing a GSK3- beta molecule to a putative inhibitor, and measuring the specific enzymatic activity of said GSK3- beta molecule |
| 04/22/2008 | US7361475 Compositions and methods relating to colon specific genes and proteins |
| 04/22/2008 | US7361463 Degradation resistant antihypoxic agents for use in treatment and prevention of hypoxia and ischemic related tissue damage |
| 04/22/2008 | US7361353 Genomic sequence that encode ptorprotein; drug for prevention, therapy of infections; induce immunology response |
| 04/22/2008 | US7361340 Specifically recognizing human oculospanin and having cytotoxic activity against cancer cells, cancer therapy |
| 04/22/2008 | US7361338 Methods to inhibit growth of prostate cancer cells |
| 04/22/2008 | CA2438213C Modulated release particles for aerosol delivery |
| 04/22/2008 | CA2353417C Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith |
| 04/22/2008 | CA2319433C Targeted delivery of biologically active media |
| 04/22/2008 | CA2112395C Cytosine deaminase negative selection system for gene transfer techniques and therapies |
| 04/17/2008 | WO2008046038A2 Intranasal therapeutics for neuroprotection |
| 04/17/2008 | WO2008045548A2 Codon optimized cftr |
| 04/17/2008 | WO2008045486A2 Nanoparticle compositions for controlled delivery of nucleic acids |
| 04/17/2008 | WO2008044787A1 Composition for treating cancer using dref as molecular target |
| 04/17/2008 | WO2008043782A2 Modulation of cd1b or cd1d expression in autoimmune disorders |
| 04/17/2008 | WO2008043561A2 Influenza targets |
| 04/17/2008 | WO2008043181A1 Augmenting stem cell populations by modulating t-cell protein tyrosine phosphatase (tc-ptp) |
| 04/17/2008 | WO2008043180A1 Immunostimulatory composition comprising recombinant bcg mycobacterium expressing mammalian cysteine protease |
| 04/17/2008 | WO2008024427A3 A virus-like platform for rapid vaccine discovery |
| 04/17/2008 | WO2008017636A3 Genes and proteins of brachyspira hyodysenteriae and uses thereof |
| 04/17/2008 | WO2007134907A3 Gm-csf gene therapy for treatment of crohn's disease using an improved regulated expression system |
| 04/17/2008 | WO2007121054A3 Nucleic acids for apoptosis of cancer cells |
| 04/17/2008 | WO2007084773A3 Enhanced production of infectious parvovirus vectors in insect cells |
| 04/17/2008 | WO2007050648A9 Use of tumor necrosis factor- receptor p75 for treatment of ischemia-induced neovascularization |
| 04/17/2008 | US20080091004 Small interfering RNA sequence for use in the prevention and treatment of cell proliferative disorders; gene expression inhibition; antisense agents |
| 04/17/2008 | US20080091003 Small interfering RNA sequence for use in the prevention and treatment of cell proliferative disorders; gene expression inhibition; antisense agents |
| 04/17/2008 | US20080091002 Functional and hyperfunctional siRNA directed against Bcl-2 |
| 04/17/2008 | US20080091001 Small interfering RNA sequence for use in the prevention and treatment of cell proliferative disorders; gene expression inhibition; antisense agents |
| 04/17/2008 | US20080090843 Pharmaceutical formulation for treatment of HBV infection comprising a compound that inhibits the activity of a Src kinase in an amount effective to inhibit HBV replication and a pharmaceutically acceptable carrier |
| 04/17/2008 | US20080090755 Follistatin Variant Polypeptide |
| 04/17/2008 | US20080090281 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 04/17/2008 | US20080090270 Neuronal binding protein for use tool in identifying modulators for prevention and treatment of nervous system disorders |
| 04/17/2008 | US20080089950 Lymphoid tissue inducers and an immunomodulatory agent; proliferative disorders, infectious diseases, cardiovascular diseases, inflammatory disorders and autoimmune disorders |
| 04/17/2008 | US20080089938 Compositions and methods for polynucleotide delivery |
| 04/17/2008 | US20080089931 EphA2, EphA4 and LMW-PTP and methods of treatment of hyperproliferative cell disorders |
| 04/17/2008 | US20080089908 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 04/17/2008 | US20080089907 Modified vaccinia Ankara virus variant |
| 04/17/2008 | US20080089895 Using antisense agents specific to lymphocyte membrane protein (TIRC7) as therapeutic tools in treatment and prevention of cell proliferative, vision and ischemic heart defects; wound healing agents |
| 04/17/2008 | US20080089887 Members of the FC Receptor Homolog Gene Family (FcRH1-3,6) Related Reagents and Uses Thereof |
| 04/17/2008 | US20080089882 Novel Polypeptide Useful for Cancer Diagnosis and Treatment |
| 04/17/2008 | US20080089872 Method for purifying pluri-differentiated mesenchymal progenitor cells |
| 04/17/2008 | US20080089869 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer |
| 04/17/2008 | US20080089864 Viral sequences for targeted replication in tumor cells |
| 04/17/2008 | US20080089863 Non-Integrative And Non-Replicative Lentivirus , Preparation And Uses Thereof |
| 04/17/2008 | CA2665620A1 Codon optimized cftr |
| 04/16/2008 | EP1911459A1 Lymphangiogenesis promoter |
| 04/16/2008 | EP1910525A1 Modulation of sphingosine kinase signalling |
| 04/16/2008 | EP1910524A1 Modulation of sphingosine kinase signalling |
| 04/16/2008 | EP1910523A1 Modulation of egfr signalling by modulation of sphingosine kinase signalling |
| 04/16/2008 | EP1909827A2 The modulation of immunity and ceacam1 activity |
| 04/16/2008 | EP1909581A2 Adipose tissue stem cells, perivascular cells and pericytes |
| 04/16/2008 | EP1660665B1 Chimaeric vector system |
| 04/16/2008 | EP1250434B1 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 04/16/2008 | EP1250155B1 Angiogenesis and vascular permeability modulators and inhibitors |
| 04/16/2008 | EP1223952B1 Methods for treatment of solid tumors and metastasis by gene therapy |
| 04/16/2008 | EP1222289B1 Chimeric immunogenic compositions and nucleic acids encoding them |
| 04/16/2008 | EP0922110B1 Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat |
| 04/16/2008 | CN101163796A Cationic lipids and methods of use |
| 04/16/2008 | CN101161676A Saltant APOBEC3G molecule inhibiting HIV reproduction and uses thereof |
| 04/16/2008 | CN100381460C HER-2 analogue antigen epitope and peptide containing said epitope |
| 04/16/2008 | CN100381455C The novel antisense-oligos with better stability and antisense effect |
| 04/16/2008 | CN100381176C Method for introducing nucleic acids and other biologially active molecules into nucleus of higher exkaryotic cells by means of electrical current |
| 04/15/2008 | US7358354 Administering genetically engineered vectors to modulate lymphocytes; transfecting macrophages; used for prophylaxis or treatments for cancers or immune-related disorders |
| 04/15/2008 | US7358351 Endothelial cell expression patterns |
| 04/15/2008 | US7358350 Oncogene, recombinant protein derived therefrom, and uses thereof |
| 04/15/2008 | US7358341 Secreted protein for use in diagnosis, prevention and treatment of thyroid gland disorders |
| 04/15/2008 | US7358333 Polypeptides of the IFNα-5 gene |
| 04/15/2008 | US7358234 Induction of a protective immune response through microprojectiles coated with a DNA sequence encoding an immunogenic protein |
| 04/15/2008 | US7358228 Methods of treating pain using neurotrophic factors |
| 04/15/2008 | US7358222 Administering a therapeutically effective amount of an epidermal growth factor receptor (EGF-R) antagonist for therapy of hypersecretion of mucus in lungs |
| 04/15/2008 | US7358086 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products |
| 04/15/2008 | US7358074 Human phosphatase RET31, and variants thereof |
| 04/15/2008 | US7358068 For use as therapeutic agents in viral infections by human and animal viruses and in cancers caused by oncogene viruses; non-sequence complementary mode of action; drug screening |
| 04/15/2008 | US7357932 Surface protein of Neisseria bacteria |
| 04/15/2008 | US7357931 Gene expression inhibition; drug screening; peroxisome proliferator-activated receptor agonists such as fenofibrate |
| 04/15/2008 | US7357927 Death domain containing receptors |
| 04/15/2008 | CA2405265C Method of preventing or treating diabetes |
| 04/10/2008 | WO2008042686A2 Multifunctional carriers for the delivery of nucleic acids and methods of use thereof |
| 04/10/2008 | WO2008042436A2 Biomarkers and assays for the treatment of cancer |